|

Pioglitazone 45 mg Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 4: 1

Top Sponsors

  • The University of Texas Health Science Center at San Antonio1
  • Karolinska Institutet1

Indications

  • Diabetes2
  • Type 1 Diabetes Mellitus1
  • Type 2 Diabetes1

Other1 trial

Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes
N/A

San Antonio, Texas1 trial

Dapagliflozin Plus Pioglitazone in T1DM

University Health System Texas Diabetic Institute

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.